Prognostic indices for brain metastases--usefulness and challenges
about
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies.Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.Recursive partitioning analysis for the prediction of stereotactic radiosurgery brain metastases lesion control.Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score.Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries.Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation.Survival prediction score: a simple but age-dependent method predicting prognosis in patients undergoing palliative radiotherapy.Brain metastases in cancer patients attending a Gamma Knife Center: A study from a single institute in IranUpdates in the management of brain metastases.Heart rate variability is associated with survival in patients with brain metastasis: a preliminary report.Development of a score predicting survival after palliative reirradiation.Decision support systems for incurable non-small cell lung cancer: a systematic reviewImpact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.Retrospective study of 229 surgically treated patients with brain metastases: Prognostic factors, outcome and comparison of recursive partitioning analysis and diagnosis-specific graded prognostic assessment.Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research.Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center.Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population.Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels.
P2860
Q33953465-B0BEA892-AC64-4E1F-B639-96348CDD93F9Q34242516-2F3D1347-6416-42CD-9467-F3D65169F8CAQ34581358-C8DAF008-C5B3-4826-8658-0A0197A38BECQ34582713-BAF1F154-DC9E-4002-B9A2-EBFF9648CF4AQ34594528-CFF72287-E679-42B7-9623-36DF18BF333EQ35549453-3A3637FC-42E3-4116-B207-0E97B664CA68Q36324927-11C135F8-A99D-4E18-8E79-9D017CEF3CF9Q36428221-223EA08D-F8D0-4D5B-9C5C-FE93EEF10DBAQ36577574-B56E04A5-C29F-44F7-A550-C1908EFFAC8CQ36728245-8646CD3E-83D0-4C89-9D3C-E2998E90A5A5Q36924250-95BC4AA6-B587-4023-802E-BC2EC5DB8E36Q38632096-64C4AAE5-DC53-4B26-8D3C-ADA215F2CFCDQ38650503-9C86180E-D958-4B22-90CC-F1D0504ABF6EQ38887451-60DAD950-96DD-4316-8C1A-05BCFA1BCA57Q42061729-5F3224F6-E4FF-4846-AF9A-B7F4D62258C0Q42207668-076188E7-8A9B-4B86-B544-99061FA50C91Q42284446-D36A96C9-E37C-4CAA-83E7-B3DB349C4DF3Q43978547-F9F58C34-EBF2-4179-AC11-1C6E3CE8CFA8Q45140192-7FBDD47E-2B4D-4D76-A83E-3251844DB8FEQ47113972-79658B17-2E8C-4A4F-86DF-6BE4EAC13264Q47742544-94934032-12EE-44E7-97CD-D298D3A1A722Q48164906-131AB7D5-11F8-49A3-83B2-318428FF6565Q48266423-B4A17A04-98A1-450B-B4AB-3BF75CEC510BQ48308810-432F8A5C-EF0D-40D7-8C9A-C454164104ACQ49247940-0592D603-BA10-40B3-B669-5FAF2E0C115EQ51746643-178CDDB7-7615-4F32-97C9-6F24B78DE765Q55394617-3533F24C-FBB7-4406-8A26-10FDAF9316BE
P2860
Prognostic indices for brain metastases--usefulness and challenges
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic indices for brain metastases--usefulness and challenges
@ast
Prognostic indices for brain metastases--usefulness and challenges
@en
type
label
Prognostic indices for brain metastases--usefulness and challenges
@ast
Prognostic indices for brain metastases--usefulness and challenges
@en
prefLabel
Prognostic indices for brain metastases--usefulness and challenges
@ast
Prognostic indices for brain metastases--usefulness and challenges
@en
P2860
P356
P1433
P1476
Prognostic indices for brain metastases--usefulness and challenges
@en
P2093
Carsten Nieder
P2860
P2888
P356
10.1186/1748-717X-4-10
P50
P5008
P577
2009-03-04T00:00:00Z
P6179
1017792067